KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Cash & Current Investments (2018 - 2025)

Historic Cash & Current Investments for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $345.2 million.

  • Progyny's Cash & Current Investments rose 4644.79% to $345.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.2 million, marking a year-over-year increase of 4644.79%. This contributed to the annual value of $228.0 million for FY2024, which is 3857.13% down from last year.
  • According to the latest figures from Q3 2025, Progyny's Cash & Current Investments is $345.2 million, which was up 4644.79% from $305.1 million recorded in Q2 2025.
  • Progyny's 5-year Cash & Current Investments high stood at $371.8 million for Q1 2024, and its period low was $94.0 million during Q2 2021.
  • In the last 5 years, Progyny's Cash & Current Investments had a median value of $228.0 million in 2024 and averaged $220.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 13799.2% in 2023, then plummeted by 3857.13% in 2024.
  • Over the past 5 years, Progyny's Cash & Current Investments (Quarter) stood at $119.4 million in 2021, then soared by 58.52% to $189.3 million in 2022, then skyrocketed by 96.03% to $371.1 million in 2023, then plummeted by 38.57% to $228.0 million in 2024, then surged by 51.44% to $345.2 million in 2025.
  • Its Cash & Current Investments stands at $345.2 million for Q3 2025, versus $305.1 million for Q2 2025 and $256.1 million for Q1 2025.